135 related articles for article (PubMed ID: 6929355)
1. [Studies on the shift of cefmetazole into the gastrointestinal tract (author's transl)].
Minamitani M; Hayashi H; Tohma T; Kojima T; Sahashi Y; Terao T
Jpn J Antibiot; 1980 Jan; 33(1):10-7. PubMed ID: 6929355
[TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetic studies of cephalothin, cefazolin and cefmetazole in the neonates and the premature babies.
Sakata Y
Kurume Med J; 1980; 27(4):275-98. PubMed ID: 6946258
[No Abstract] [Full Text] [Related]
3. [Profile of cefmetazole. II. Absorption, excretion, distribution and metabolism (author's transl)].
Kawada Y
Kansenshogaku Zasshi; 1979 Feb; 53(2):66-74. PubMed ID: 115937
[No Abstract] [Full Text] [Related]
4. Pharmacokinetics of the new cephalosporins.
Brogard JM; Comte F
Antibiot Chemother (1971); 1982; 31():145-210. PubMed ID: 6277241
[No Abstract] [Full Text] [Related]
5. [Studies on absorption and excretion of cefmetazole in neonates and excretion into the bile of infants with congenital biliary atresia (author's transl)].
Yura J; Tsuruga N; Hayashi S
Jpn J Antibiot; 1981 Jun; 34(6):903-6. PubMed ID: 6945450
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of E. coli meningitis with cefmetazole. Report of two cases with favorable response and determination of the concentrations in CSF (author's transl)].
Kobayashi Y; Morikawa Y; Haruta T; Fujiwara T; Kuroki S
Jpn J Antibiot; 1979 May; 32(5):598-605. PubMed ID: 379388
[TBL] [Abstract][Full Text] [Related]
7. [Examination of blood levels and urinary excretion of cefmetazole in the mature and immature neonates (author's transl)].
Nanri S; Sunakawa K; Yamashita N; Akita H; Hotta M; Ichihashi Y; Ishikawa K; Okazaki K; Kanemitsu T; Ri S
Jpn J Antibiot; 1981 Jun; 34(6):874-9. PubMed ID: 6945447
[TBL] [Abstract][Full Text] [Related]
8. [Experimental and clinical studies on 6059-S (author's transl)].
Toyonaga Y; Sugita M; Kurosu Y; Kumagai K; Hori M; Takahashi T
Jpn J Antibiot; 1981 May; 34(5):764-81. PubMed ID: 6457175
[TBL] [Abstract][Full Text] [Related]
9. [Clinical experiences with cefmetazole for peritonitis and biliary tract infections with special reference to excretion of cefmetazole into bile (author's transl)].
Saito T; Yamada Y; Yokoyama S
Jpn J Antibiot; 1979 Apr; 32(4):504-8. PubMed ID: 459081
[No Abstract] [Full Text] [Related]
10. Absorption, distribution, excretion and metabolism of cefmetazole in cynomolgus monkeys.
Shindo H; Kawai K; Ikeda T; Igarashi I; Sugawara S
J Antibiot (Tokyo); 1982 Jun; 35(6):742-54. PubMed ID: 6956564
[TBL] [Abstract][Full Text] [Related]
11. [Laboratory and clinical studies of cefmetazole in serious infection by Staphylococcus (author's transl)].
Motohiro T; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Onoda Y; Kusayanagi T; Tsuboi M; Toubo Y; Yamamoto M; Komatsu R; Tanaka C; Baba Y
Jpn J Antibiot; 1982 Mar; 35(3):821-34. PubMed ID: 6954289
[TBL] [Abstract][Full Text] [Related]
12. [Cefmetazole in the treatment of bacterial infections in the newborn (author's transl)].
Kobayashi Y; Haruta T; Morikawa Y; Kuroki S; Okura K; Fujiwara T
Jpn J Antibiot; 1980 Nov; 33(11):1237-46. PubMed ID: 6941035
[TBL] [Abstract][Full Text] [Related]
13. Enhanced small intestinal absorption of cefmetazole and cefoxitin in rats in the presence of non-surfactant adjuvants.
Nishihata T; Takahagi H; Higuchi T
J Pharm Pharmacol; 1983 Feb; 35(2):124-5. PubMed ID: 6131983
[No Abstract] [Full Text] [Related]
14. Effect of salicylate on the rectal absorption of lidocaine, levodopa, and cefmetazole in rats.
Nishihata T; Rytting JH; Higuchi T
J Pharm Sci; 1982 Aug; 71(8):869-72. PubMed ID: 6956717
[TBL] [Abstract][Full Text] [Related]
15. [A study on cefmetazole in the neonatal period (author's transl)].
Iwai N; Sasaki A; Taneda Y; Inokuma K
Jpn J Antibiot; 1981 Jun; 34(6):881-92. PubMed ID: 6945448
[TBL] [Abstract][Full Text] [Related]
16. [A study of clinical application of cefmetazole in perinatal period (author's transl)].
Cho N; Fukunaga K; Kunii K
Jpn J Antibiot; 1981 Jun; 34(6):915-24. PubMed ID: 6945452
[TBL] [Abstract][Full Text] [Related]
17. [Basic study on efficacy of cefmetazole against osseous and articular infections (author's transl)].
Kawashima M; Tamura H; Kitahara Y; Jinyama K
Jpn J Antibiot; 1982 Mar; 35(3):835-9. PubMed ID: 6954290
[TBL] [Abstract][Full Text] [Related]
18. Reduction of cephamycin concentrations at the infection site in mice with experimental peritoneal infection caused by cephalosporinase-producing bacteria.
Minami S; Araki H; Watanabe Y; Yasuda T; Takai A; Saikawa I; Mitsuhashi S
Antimicrob Agents Chemother; 1986 Feb; 29(2):376-8. PubMed ID: 3521482
[TBL] [Abstract][Full Text] [Related]
19. [Experimental studies of cefmetazole in the field of dermatology].
Suwaki M; Kashiwa N; Nohara N
Jpn J Antibiot; 1982 Aug; 35(8):1957-60. PubMed ID: 6961240
[TBL] [Abstract][Full Text] [Related]
20. [A study of safety of cefmetazole (CS-1170) in pregnant women during the perinatal stage (author's transl)].
Jpn J Antibiot; 1981 Jun; 34(6):907-14. PubMed ID: 6945451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
